Daniel Loeb’s Lam Research LRCX Stock Holding History

Daniel Loeb’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-75,000	Closed	-$16M	–	47
2026 Q1	$16M	Buy	+75,000	New	+$16.8M	0.77%	22

Other funds holding LRCX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Daniel Loeb's LRCX Position: Q2 2026 in Review

Daniel Loeb sold out of Lam Research (LRCX) in Q2 2026, closing a stake of 75,000 shares — an estimated $16M sold.

Daniel Loeb first reported a position in LRCX in Q1 2026 and held it in 1 quarter. The position peaked at $16M in Q1 2026. 3,114 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

Daniel Loeb reported no remaining Lam Research position as of Q2 2026 after selling out during the quarter.
Daniel Loeb sold 75,000 Lam Research shares in Q2 2026, an estimated $16M.
Daniel Loeb first reported a position in Lam Research in Q1 2026 and held it in 1 quarter.
Daniel Loeb's Lam Research position peaked at $16M in Q1 2026.
3,114 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Third Point's 13F filing for Q2 2026, filed 14 Aug 2026.